Biotech Values

[biotech_researcher]

It was encouraging to see the bounce-back, which was presumably driven by value investors who think the EV is simply too low, even under the new STOP-HE parameters.

Exactly correct, Dew. Exceptionally low market cap for a read out in a year or so.. However, an equity raise in 2016 is almost certain. Exit stage left toward the end of 2015, early 2016.